Institute of Cancer and Genomic Sciences

We make a powerful contribution to understanding how genetic abnormalities within cancer cells lead to disease. Through Birmingham’s Cancer Research UK Clinical Trials Unit- one of Europe’s leading clinical trials unit- we use this information to design and rigorously assess new and proven cancer treatments. In so doing, we will play a significant role in accelerating the ultimate control of cancer.

Also in 'Institute of Cancer and Genomic Sciences'

Latest videos

Life Sciences in Six - Dr Joanna Parish

My story: Graham Silk

Precision Medicine: Diagnostic medical genetics

Dr Andrew Peet - Support our brain cancer in children research

Latest news

Posted 21 February 2018

Bloodwise: Fighting AML by getting white blood cells to grow up

Professors Conny Bonifer and Peter Cockerill have found a way to restore healthy blood production in acute myeloid leukaemia (AML) by helping cells stuck in an immature state to develop into mature blood cells, as Bloodwise reports.

View all news